The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for paclitaxel formulations, highlighting the risk of medication error ...

Sandoz has launched a generic paclitaxel formulation. It is the first generic of Abraxis BioScience’s (a Bristol Myers Squibb Co.) Abraxane to be approved by the Food and Drug Administration. Sandoz ...

Meitheal, through parent company Hong Kong King-Friend, launches generic paclitaxel Protein-bound paclitaxel formulation is used to treat various types of cancer, including metastatic breast cancer ...

Celgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to ...

NICE does not deem Abraxane more effective than FOLFIRINOX, in addition to the fact that it causes severe side effects. The National Institute for Health and Care Excellence has published new ...